Immunoclin Corp Marketable Securities, Gain (Loss)
Immunoclin Corp reported Marketable Securities, Gain (Loss) of $236.00 thousand for the 9-month period ending 2014-10-31, per its 10-Q filed 2014-12-22.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLoss · last filed 2014-12-22
- 2014-10-31: Marketable Securities, Gain (Loss) 9 month $236.00K.
| Period end | Marketable Securities, Gain (Loss) 9 month |
|---|---|
| 2014-10-31 | $236.00K 10-Q · filed 2014-12-22 |